Get more information on Heart Failure POC & LOC Devices Market - Request Sample Report
The Heart Failure POC & LOC Devices Market was valued at USD 95.94 million in 2023 and is expected to reach USD 401.91 million by 2032, growing at a CAGR of 17.26% over the forecast period 2024-2032.
The Heart Failure Point-of-Care (POC) and Lab-on-Chip (LOC) Devices market is witnessing accelerated growth, driven by the rising global burden of cardiovascular diseases. According to the American Heart Association (AHA), approximately 6.2 million adults in the U.S. alone have heart failure, with the prevalence projected to increase by 46% by 2030. The economic burden is equally concerning, with annual healthcare costs for heart failure expected to surpass USD 70 billion by 2035. These statistics underscore the urgent need for innovative, cost-effective diagnostic and monitoring solutions.
Technological advancements are reshaping the market landscape. For instance, Abbott's i-STAT handheld system allows rapid blood analysis for cardiac markers, providing results within minutes. Similarly, Roche Diagnostics’ cobas h 232 POC system offers real-time measurements of NT-proBNP, a critical biomarker for diagnosing heart failure. These devices are essential for decentralized healthcare delivery, particularly in remote and resource-limited settings. Moreover, the integration of artificial intelligence (AI) and the Internet of Things (IoT) in POC devices, such as portable ECG monitors equipped with cloud-based data sharing, is enhancing diagnostic accuracy and personalized care.
Demographic trends further propel market growth. The aging global population, expected to reach 1.5 billion people aged 65 and older by 2050, is particularly vulnerable to cardiovascular conditions. POC devices, such as the CardioMEMS HF System by Abbott, enable continuous monitoring of heart failure patients, reducing hospital readmissions by up to 37% as per clinical studies.
Emerging economies also present substantial opportunities. In India, where cardiovascular diseases account for over 28% of deaths annually, affordable POC solutions are being introduced to improve early diagnosis and access to care. Government initiatives, like the National Health Protection Scheme (NHPS), further support the adoption of such technologies.
With leading companies like Abbott, Roche, and Siemens Healthineers investing in innovation, and the global focus shifting toward precision medicine and early diagnosis, the Heart Failure POC and LOC Devices market is poised to grow significantly, addressing critical healthcare challenges worldwide.
Drivers
Rising demand for early detection, AI integration, and decentralized care fuels market expansion
A major driver is the rising demand for early detection and continuous monitoring of heart failure patients. As heart failure is a chronic and recurrent condition, early intervention plays a crucial role in reducing hospitalizations and improving patient outcomes. POC and LOC devices deliver real-time results, enabling healthcare providers to make swift and informed treatment decisions.
Another factor fueling market growth is the advancement in device miniaturization and the development of user-friendly designs. These improvements have made POC devices more accessible across various healthcare settings, including outpatient clinics, emergency care units, and home care. Such innovations not only enhance patient compliance but also ease the burden on traditional healthcare infrastructure, benefiting both developed and emerging markets. The incorporation of artificial intelligence (AI) and machine learning into heart failure monitoring is also contributing to market expansion. These technologies improve predictive capabilities, allowing for more proactive management of heart failure and reducing the risk of adverse events. AI-powered devices can process large datasets to anticipate heart failure episodes and trigger timely interventions.
The shift toward decentralized and home-based care is another significant driver. As healthcare costs rise and there is an increasing preference for at-home treatments, POC devices are becoming essential for patients to monitor their conditions outside clinical settings, offering greater convenience and cost-efficiency. Lastly, heightened awareness of heart failure and the focus on strengthening cardiovascular healthcare systems globally are fueling the market. Public and private investments are accelerating the development and adoption of these devices, further driving growth.
Restraints
High Costs and Accessibility Issues
The initial high costs of Heart Failure POC & LOC devices, along with the challenges in making these technologies accessible in low-resource settings, can limit widespread adoption, especially in emerging markets.
Regulatory Challenges and Device Approval Delays
Stringent regulatory requirements and lengthy approval processes for medical devices can delay the launch of new products and hinder market growth, particularly in regions with complex regulatory frameworks.
By Test Type
Proteomic testing was the dominant segment in the Heart Failure POC & LOC Devices market in 2023, accounting for a significant share of the market. This dominance can be attributed to the increasing recognition of biomarkers in the early diagnosis and management of heart failure. Proteomic tests help identify specific proteins in blood or tissues, which can reveal the presence, severity, and prognosis of heart failure. The ability to monitor protein levels for more personalized care is a major driver behind the widespread adoption of proteomic testing. In 2023, this segment contributed approximately 53.0% to the overall market due to the growing demand for precision medicine and the need for non-invasive diagnostic methods.
Genomic testing emerged as the fastest-growing segment throughout the forecast period, fueled by the expanding knowledge of genetic factors in heart failure. This testing approach offers the potential for personalized treatment by identifying genetic predispositions and enabling more accurate predictions of disease progression. As genetic research becomes increasingly integrated into clinical practice, the adoption of genomic testing in heart failure management has accelerated, with a growing number of healthcare providers incorporating genetic analysis into their diagnostic procedures.
By Technology
Microfluidics technology dominated the Heart Failure POC & LOC Devices market in 2023, holding a substantial share. This technology enables the miniaturization of diagnostic tests, allowing for quick, affordable, and accurate results. By using small sample volumes, microfluidics-based devices are ideal for point-of-care and lab-on-chip applications, making them widely adopted in heart failure management. The growing demand for rapid, in-situ diagnostics in both hospital and home care settings contributed to the strong market presence of microfluidics technology.
Array-based systems represent the fastest-growing technology segment, as they allow for the simultaneous analysis of multiple biomarkers, providing more comprehensive diagnostic results. This capability makes them particularly useful in complex conditions like heart failure, where multiple factors need to be considered for effective management. As healthcare providers continue to adopt multi-marker testing to enhance diagnostic accuracy and speed, the demand for array-based systems has surged, making it the fastest-growing technology in the market.
North America held the largest market share, driven by robust healthcare systems, high healthcare spending, and widespread adoption of advanced diagnostic technologies. The United States, in particular, is a key player, with a high prevalence of heart failure and a growing aging population. The increasing demand for early diagnosis, home-based care, and precision medicine further boosts the adoption of POC & LOC devices. Additionally, the region benefits from strong regulatory frameworks and high investments in medical device research and development.
Europe followed closely, with countries like Germany, the UK, and France seeing a growing adoption of heart failure management solutions. The region’s focus on improving cardiovascular care, along with initiatives aimed at reducing hospital readmissions, drives demand for real-time monitoring devices. Moreover, the push towards decentralized healthcare and home care solutions is fueling market growth in Europe.
In the Asia-Pacific (APAC) region, the market is expanding rapidly due to the rising burden of cardiovascular diseases, an aging population, and improving healthcare infrastructure. Countries like China and India are investing heavily in healthcare technologies, making the region a hotspot for growth. The increasing demand for affordable and accessible healthcare solutions in urban and rural areas is expected to accelerate the adoption of POC & LOC devices.
Need any customization research on Heart Failure POC & LOC Devices Market - Enquiry Now
1. Abbott
i-STAT System
Freestyle Libre
Radiometer
Cepheid
Atellica Solution
Immulite 2000 XPi
4. F. Hoffmann-La Roche Ltd.
Cobas h232
5. Quidel Corporation
Triage BNP Test
6. bioMérieux S.A.
VITEK 2
7. Trinity Biotech
Point-of-Care Immunoassays
8. Instrumentation Laboratory
GEM Premier 4000
9. Abaxis, Inc.
VetScan
10. Becton, Dickinson and Company
BD FACSPresto
11. BioTelemetry, Inc.
CardioNet
12. Masimo Corporation
Rad-97
13. Novartis AG
Entresto
14. Stryker Corporation
LifePak
In November 2024, Emory University Hospital became the first in the U.S. to perform a surgical implantation of a novel ventricular assist device (VAD) designed for patients with heart failure.
In August 2024, researchers developed a point-of-care electrochemical biosensor prototype for heart failure screening. This device, resembling a lateral flow test, can measure two biomarkers for heart failure from a drop of saliva in just 15 minutes, improving access to screening, particularly in underserved areas.
In April 2024, Roche Diagnostics India launched its Heart Failure Test for Diabetics on its point-of-care device, providing faster and more accessible testing for heart failure in diabetic patients. This development aims to improve early detection and timely intervention, enhancing patient outcomes in India.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 95.94 million |
| Market Size by 2032 | US$ 401.91 million |
| CAGR | CAGR of 17.26% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Test Type (Proteomic testing, Metabolomic testing, Genomic testing) • By Technology (Microfluidics, Array-based systems, Others) • By End-Use (Clinics, Hospitals, Homes, Assisted living healthcare facilities, Laboratory) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Abbott, Danaher Corporation, Siemens Healthineers, F. Hoffmann-La Roche Ltd., Quidel Corporation, bioMérieux S.A., Trinity Biotech, Instrumentation Laboratory, Abaxis, Inc., Becton, Dickinson and Company, BioTelemetry, Inc., Masimo Corporation, Novartis AG, Stryker Corporation |
| Key Drivers | • Rising demand for early detection, AI integration, and decentralized care fuels market expansion |
| Restraints | • High Costs and Accessibility Issues • Regulatory Challenges and Device Approval Delays |
Ans. The Heart Failure POC & LOC Devices Market is growing at a CAGR of 17.26% over the forecast period 2024-2032.
Ans Increased investment in the study of cardiovascular and heart diseases, Creation of more recent, suitable POC and LOC heart failure biomarkers are the opportunities of the market.
Ans. Heart Failure POC & LOC Devices Market is divided into three segments and they are By Test Type, By Technology, and By End User
Ans. Due to the large market players in North America who are fostering significant organic revenue growth in the worldwide heart failure POC & LOC devices market, the region led the revenue share
Ans. Proteomic Testing, Metabolomic Testing, and Genomic Testing are sub segments of by test type of the Heart Failure POC & LOC Devices Market.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Market Trends and Usage Trends (2023), by Region
5.3 Device Volume, by Region (2020-2032)
5.4 Healthcare Spending, by Region (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Heart Failure POC & LOC Devices Market Segmentation, by Test Type
7.1 Chapter Overview
7.2 Proteomic testing
7.2.1 Proteomic Testing Market Trends Analysis (2020-2032)
7.2.2 Proteomic Testing Market Size Estimates and Forecasts to 2032 (USD Million)
7.3 Metabolomic testing
7.3.1 Metabolomic Testing Market Trends Analysis (2020-2032)
7.3.2 Metabolomic Testing Market Size Estimates and Forecasts to 2032 (USD Million)
7.4 Genomic testing
7.4.1 Genomic Testing Market Trends Analysis (2020-2032)
7.4.2 Genomic Testing Market Size Estimates and Forecasts to 2032 (USD Million)
8. Heart Failure POC & LOC Devices Market Segmentation, by Technology
8.1 Chapter Overview
8.2 Microfluidics
8.2.1 Microfluidics Market Trends Analysis (2020-2032)
8.2.2 Microfluidics Market Size Estimates and Forecasts to 2032 (USD Million)
8.3 Array-based systems
8.3.1 Array-based Systems Market Trends Analysis (2020-2032)
8.3.2 Array-based Systems Market Size Estimates and Forecasts to 2032 (USD Million)
8.4 Others
8.4.1 Others Market Trends Analysis (2020-2032)
8.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Million)
9. Heart Failure POC & LOC Devices Market Segmentation, by End-use
9.1 Chapter Overview
9.2 Clinics
9.2.1 Clinics Market Trends Analysis (2020-2032)
9.2.2 Clinics Market Size Estimates and Forecasts to 2032 (USD Million)
9.3 Hospitals
9.3.1 Hospitals Market Trends Analysis (2020-2032)
9.3.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Million)
9.4 Home
9.4.1 Home Market Trends Analysis (2020-2032)
9.4.2 Home Market Size Estimates and Forecasts to 2032 (USD Million)
9.5 Assisted Living Healthcare Facilities
9.5.1 Assisted Living Healthcare Facilities Market Trends Analysis (2020-2032)
9.5.2 Assisted Living Healthcare Facilities Market Size Estimates and Forecasts to 2032 (USD Million)
9.6 Laboratory
9.6.1 Laboratory Market Trends Analysis (2020-2032)
9.6.2 Laboratory Market Size Estimates and Forecasts to 2032 (USD Million)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.2.3 North America Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.2.4 North America Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.2.5 North America Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.2.6 USA
10.2.6.1 USA Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.2.6.2 USA Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.2.6.3 USA Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.2.7 Canada
10.2.7.1 Canada Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.2.7.2 Canada Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.2.7.3 Canada Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.2.8 Mexico
10.2.8.1 Mexico Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.2.8.2 Mexico Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.2.8.3 Mexico Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.3.1.3 Eastern Europe Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.3.1.4 Eastern Europe Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.3.1.5 Eastern Europe Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.3.1.6 Poland
10.3.1.6.1 Poland Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.3.1.6.2 Poland Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.3.1.6.3 Poland Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.3.1.7 Romania
10.3.1.7.1 Romania Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.3.1.7.2 Romania Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.3.1.7.3 Romania Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.3.1.8.2 Hungary Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.3.1.8.3 Hungary Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.3.1.9 turkey
10.3.1.9.1 Turkey Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.3.1.9.2 Turkey Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.3.1.9.3 Turkey Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.3.1.10.2 Rest of Eastern Europe Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.3.1.10.3 Rest of Eastern Europe Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.3.2.3 Western Europe Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.3.2.4 Western Europe Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.3.2.5 Western Europe Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.3.2.6 Germany
10.3.2.6.1 Germany Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.3.2.6.2 Germany Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.3.2.6.3 Germany Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.3.2.7 France
10.3.2.7.1 France Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.3.2.7.2 France Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.3.2.7.3 France Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.3.2.8 UK
10.3.2.8.1 UK Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.3.2.8.2 UK Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.3.2.8.3 UK Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.3.2.9 Italy
10.3.2.9.1 Italy Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.3.2.9.2 Italy Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.3.2.9.3 Italy Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.3.2.10 Spain
10.3.2.10.1 Spain Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.3.2.10.2 Spain Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.3.2.10.3 Spain Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.3.2.11.2 Netherlands Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.3.2.11.3 Netherlands Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.3.2.12.2 Switzerland Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.3.2.12.3 Switzerland Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.3.2.13 Austria
10.3.2.13.1 Austria Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.3.2.13.2 Austria Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.3.2.13.3 Austria Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.3.2.14.2 Rest of Western Europe Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.3.2.14.3 Rest of Western Europe Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.4.3 Asia Pacific Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.4.4 Asia Pacific Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.4.5 Asia Pacific Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.4.6 China
10.4.6.1 China Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.4.6.2 China Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.4.6.3 China Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.4.7 India
10.4.7.1 India Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.4.7.2 India Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.4.7.3 India Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.4.8 Japan
10.4.8.1 Japan Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.4.8.2 Japan Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.4.8.3 Japan Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.4.9 South Korea
10.4.9.1 South Korea Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.4.9.2 South Korea Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.4.9.3 South Korea Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.4.10 Vietnam
10.4.10.1 Vietnam Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.4.10.2 Vietnam Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.4.10.3 Vietnam Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.4.11 Singapore
10.4.11.1 Singapore Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.4.11.2 Singapore Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.4.11.3 Singapore Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.4.12 Australia
10.4.12.1 Australia Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.4.12.2 Australia Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.4.12.3 Australia Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.4.13.2 Rest of Asia Pacific Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.4.13.3 Rest of Asia Pacific Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.5.1.3 Middle East Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.5.1.4 Middle East Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.5.1.5 Middle East Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.5.1.6 UAE
10.5.1.6.1 UAE Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.5.1.6.2 UAE Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.5.1.6.3 UAE Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.5.1.7.2 Egypt Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.5.1.7.3 Egypt Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.5.1.8.2 Saudi Arabia Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.5.1.8.3 Saudi Arabia Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.5.1.9.2 Qatar Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.5.1.9.3 Qatar Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.5.1.10.2 Rest of Middle East Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.5.1.10.3 Rest of Middle East Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.5.2.3 Africa Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.5.2.4 Africa Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.5.2.5 Africa Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.5.2.6.2 South Africa Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.5.2.6.3 South Africa Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.5.2.7.2 Nigeria Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.5.2.7.3 Nigeria Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.5.2.8.2 Rest of Africa Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.5.2.8.3 Rest of Africa Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.6.3 Latin America Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.6.4 Latin America Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.6.5 Latin America Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.6.6 Brazil
10.6.6.1 Brazil Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.6.6.2 Brazil Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.6.6.3 Brazil Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.6.7 Argentina
10.6.7.1 Argentina Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.6.7.2 Argentina Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.6.7.3 Argentina Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.6.8 Colombia
10.6.8.1 Colombia Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.6.8.2 Colombia Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.6.8.3 Colombia Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
10.6.9.2 Rest of Latin America Heart Failure POC & LOC Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
10.6.9.3 Rest of Latin America Heart Failure POC & LOC Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
11. Company Profiles
11.1 Danaher Corporation
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 Abbott
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 Siemens Healthineers
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 F. Hoffmann-La Roche Ltd.
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 Quidel Corporation
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 bioMérieux S.A.
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 Trinity Biotech
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 Instrumentation Laboratory
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 Becton, Dickinson and Company
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
11.10 Novartis AG
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Test Type
Proteomic testing
Metabolomic testing
Genomic testing
By Technology
Microfluidics
Array-based systems
Others
By End-Use
Clinics
Hospitals
Home
Assisted living healthcare facilities
Laboratory
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Antiepileptic Drugs Market size was estimated at USD 18.21 billion in 2023 and is expected to reach USD 26.30 billion by 2031 at a CAGR of 4.70% during the forecast period of 2024-2031.
The Nucleotide Market Size was valued at USD 0.83 Billion in 2023, and is expected to reach USD 1.61 Billion by 2032, and grow at a CAGR of 8.01% over the forecast period 2024-2032.
The Digital Pathology Market was valued at USD 1.01 billion in 2023 and is expected to reach USD 2.92 billion by 2032, growing at a CAGR of 12.54% over the forecast period 2024-2032.
Protein Crystallization Market was valued at USD 1.35 Bn in 2023 and is expected to reach USD 2.83 Bn by 2032 and grow at a CAGR of 8.57% from 2024 to 2032.
The Blood Transfusion Diagnostics Market was estimated at USD 4.70 billion in 2022 and is poised to reach 8.38 billion in 2030 anticipated to expand at a compound annual growth rate approx. CAGR of 7.2% for the forecast period of 2023-2030.
The Biotechnology Market size was valued at USD 2100 Billion in 2023 and is expected to reach USD 6430 Billion by 2032 and grow at a CAGR of 13.29% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
